Conart FY26 net profit rises 39% to ₹3.73 crore

1 min read     Updated on 30 May 2026, 09:12 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Conart Engineers Limited reported a 39.2% year-on-year increase in net profit to ₹3.73 crore for FY26, driven by a rise in revenue from operations to ₹6.22 crore. The statutory auditors issued an unmodified opinion on the standalone financial results approved by the Board on May 30, 2026.

powered bylight_fuzz_icon
41421018

*this image is generated using AI for illustrative purposes only.

Conart Engineers Limited reported a 39.2% year-on-year increase in net profit to ₹3.73 crore for the financial year ended March 31, 2026. The company's revenue from operations rose to ₹6.22 crore from ₹5.65 crore in the previous year. The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026.

Financial Performance

The company recorded a total income of ₹6.41 crore for FY26, up from ₹5.70 crore in FY25. Total expenses for the year increased to ₹5.90 crore from ₹5.32 crore. Profit before tax for the year stood at ₹5.02 crore, compared to ₹3.88 crore in the prior year.

For the quarter ended March 31, 2026, net profit was ₹1.11 crore, while revenue from operations stood at ₹1.56 crore. In the corresponding quarter of the previous year, the company reported a net profit of ₹1.25 crore on revenue of ₹2.19 crore.

Segment and Operational Details

Conart Engineers operates in a single business segment: construction activity. The statutory auditors, M/s. Govind Prasad & Co., issued an audit report with an unmodified opinion on the standalone financial results.

Metric FY26 (₹ in crore) FY25 (₹ in crore)
Net Profit 3.73 2.68
Revenue from Operations 6.22 5.65
Total Income 6.41 5.70
Total Expenses 5.90 5.32
Profit Before Tax 5.02 3.88

Board Meeting and Trading Window

The board meeting commenced at 3:30 pm and concluded at 5:00 pm on May 30, 2026. The trading window for designated persons, which was closed on April 1, 2026, is scheduled to reopen on June 2, 2026.

Historical Stock Returns for Conart Engineers

1 Day5 Days1 Month6 Months1 Year5 Years
-2.08%-0.46%-6.73%+1.52%-6.64%+542.38%

What strategic initiatives will Conart Engineers implement to sustain the 39.2% profit growth in FY27?

How will the company manage the rising expense trends observed in FY26 to protect future margins?

Does the decline in Q4 net profit compared to the prior year signal potential headwinds in the construction sector?

Conart Engineers secures ₹15.41 crore order from Apothecon Pharmaceuticals

1 min read     Updated on 27 May 2026, 03:24 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Conart Engineers Limited has secured a work order worth approximately ₹15.41 crore from Apothecon Pharmaceuticals Private Limited for civil construction work in Gujarat. The project for LVAPI-6 Services at PO Dabhasa, Vadodara, is to be executed within 12 months. The order value excludes GST and may vary based on the final layout plan.

powered bylight_fuzz_icon
41421231

*this image is generated using AI for illustrative purposes only.

Conart Engineers has secured a work order valued at approximately ₹15.41 crore from Apothecon Pharmaceuticals Private Limited for civil construction work in Gujarat. The project involves LVAPI-6 Services at PO Dabhasa, Padra, in the Vadodara district. The order, received on May 26, 2026, is expected to be executed within 12 months of the purchase order.

The contract value excludes GST and is subject to adjustments based on any changes in the final layout plan or additional work requirements. The terms and conditions of the order follow standard construction industry practices. The order has been awarded by a domestic entity, and the project site is located within India.

Conart Engineers disclosed that neither the promoter group nor group companies hold any interest in the entity awarding the contract. The company confirmed that the transaction does not fall under related party transactions. The intimation was made to the stock exchange pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The following table outlines the key details of the order:

Parameter Details
Name of Client M/s. Apothecon Pharmaceuticals Private Limited
Nature of Order Civil construction work of LVAPI-6 Services
Location PO Dabhasa, Padra, Dist. Vadodara, Gujarat
Order Value Approx ₹15.41 Crores (excluding GST)
Execution Period Within 12 months of PO
Date of Receipt 26-May-26 at 04.30 PM

The company submitted the details in compliance with SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The work order represents a new addition to the company's order book in the civil construction segment.

Historical Stock Returns for Conart Engineers

1 Day5 Days1 Month6 Months1 Year5 Years
-2.08%-0.46%-6.73%+1.52%-6.64%+542.38%

How will this new order impact Conart Engineers' revenue projections for the current fiscal year?

Does this contract signal a strategic shift towards expanding operations in the pharmaceutical infrastructure sector?

What are the potential margin implications given the exclusion of GST and the possibility of layout plan adjustments?

More News on Conart Engineers

1 Year Returns:-6.64%